Abstract:Autophagy is a protective and life-sustaining process in which cytoplasmic components are packaged into double-membrane vesicles and targeted to lysosomes for degradation. This process of cellular self-digestion is an essential stress response and is cytoprotective by removing damaged organelles and proteins that threaten the cell’s survival. Key outcomes include energy generation and recycling of metabolic precursors. In the immune system, autophagy regulates processes such as antigen uptake and presentation, removal of pathogens, survival of short- and long-lived immune cells, and cytokine-dependent inflammation. In all cases, a window of optimal autophagic activity appears critical to balance catabolic, reparative, and inflammation-inducing processes. Dysregulation of autophagosome formation and autophagic flux can have deleterious consequences, ranging from a failure to “clean house” to the induction of autophagy-induced cell death. Abnormalities in the autophagic pathway have been implicated in numerous autoimmune diseases. Genome-wide association studies have linked polymorphisms in autophagy-related genes with predisposition for tissue-destructive inflammatory disease, specifically in inflammatory bowel disease and systemic lupus erythematosus. Although the precise mechanisms by which dysfunctional autophagy renders the host susceptible to continuous inflammation remain unclear, autophagy’s role in regulating the long-term survival of adaptive immune cells has recently surfaced as a defect in multiple sclerosis and rheumatoid arthritis. Efforts are underway to identify autophagy-inducing and autophagy-suppressing pharmacologic interventions that can be added to immunosuppressive therapy to improve outcomes of patients with autoimmune disease.

Autophagy in Regulatory T Cells: A Double‐edged Sword in Disease Settings

Autophagy in regulatory T cells: A double-edged sword in disease settings

Autophagy in T‐cell differentiation, survival and memory

Autophagy Regulators As Potential Cancer Therapeutic Agents: A Review

Modulation of the Immunity and Inflammation by Autophagy

Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges

The Progress and Prospect of Regulatory T Cells in Autoimmune Diseases

Improving regulatory T cell-based therapy: insights into post-translational modification regulation

Autophagy in T‐cell development, activation and differentiation

Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations

Manipulating Regulatory T Cells: a Promising Strategy to Treat Autoimmunity.

Autophagy repression by antigen and cytokines shapes mitochondrial, migration and effector machinery in CD8 T cells.

Interactions Between Autophagy and Inhibitory Cytokines

Autophagy-associated immune responses and cancer immunotherapy.

Molecular Mechanism for Impaired Suppressive Function of Tregs in Autoimmune Diseases: A Summary of Cell‐intrinsic and Cell‐extrinsic Factors

Pathological Conditions Re-Shape Physiological Tregs into Pathological Tregs

Autophagy in autoimmune disease

Autophagy and Immune Tolerance.

Research Progress on Regulatory T Cells and Their Relationship with Autoimmune Diseases

Autophagy and Cellular Immune Responses.

Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies